Boston Scientific ROE 2006-2019 | BSX

Current and historical return on equity (ROE) values for Boston Scientific (BSX) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Boston Scientific ROE for the three months ending September 30, 2019 was 23.10%.
Boston Scientific ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-09-30 $1.09B $9.70B 11.76%
2019-06-30 $1.40B $9.43B 15.65%
2019-03-31 $1.80B $9.23B 21.15%
2018-12-31 $1.67B $8.73B 21.03%
2018-09-30 $0.67B $8.29B 8.91%
2018-06-30 $0.52B $7.74B 7.09%
2018-03-31 $0.11B $7.03B 1.55%
2017-12-31 $0.10B $7.01B 1.44%
2017-09-30 $0.84B $7.59B 11.79%
2017-06-30 $0.79B $7.24B 11.46%
2017-03-31 $0.44B $7.05B 6.57%
2016-12-31 $0.35B $6.73B 5.36%
2016-09-30 $0.08B $6.48B 1.27%
2016-06-30 $-0.35B $6.22B -5.43%
2016-03-31 $-0.04B $6.46B -0.56%
2015-12-31 $-0.24B $6.32B -3.70%
2015-09-30 $-0.40B $6.41B -6.10%
2015-06-30 $-0.16B $6.58B -2.36%
2015-03-31 $-0.25B $6.50B -3.86%
2014-12-31 $-0.12B $6.46B -1.81%
2014-09-30 $0.29B $6.70B 4.38%
2014-06-30 $0.24B $6.54B 3.67%
2014-03-31 $0.37B $6.53B 5.58%
2013-12-31 $-0.12B $6.54B -1.85%
2013-09-30 $-0.17B $6.56B -2.53%
2013-06-30 $-0.83B $6.60B -12.34%
2013-03-31 $-4.54B $6.50B -64.95%
2012-12-31 $-4.07B $6.87B -49.58%
2012-09-30 $-4.02B $6.83B -43.13%
2012-06-30 $-3.22B $7.73B -30.63%
2012-03-31 $0.51B $11.40B 4.44%
2011-12-31 $0.44B $11.35B 3.85%
2011-09-30 $0.57B $11.52B 4.99%
2011-06-30 $0.62B $11.54B 5.46%
2011-03-31 $0.57B $11.37B 5.11%
2010-12-31 $-1.07B $11.30B -9.68%
2010-09-30 $-2.38B $11.04B -21.12%
2010-06-30 $-2.66B $10.89B -22.52%
2010-03-31 $-2.60B $10.78B -20.89%
2009-12-31 $-1.03B $12.30B -7.84%
2009-09-30 $-2.33B $13.30B -17.54%
2009-06-30 $-2.31B $13.41B -16.64%
2009-03-31 $-2.37B $13.28B -16.42%
2008-12-31 $-2.04B $13.17B -13.60%
2008-09-30 $-0.11B $15.69B -0.72%
2008-06-30 $-0.31B $15.64B -2.01%
2008-03-31 $-0.29B $15.39B -1.90%
2007-12-31 $-0.50B $15.10B -3.20%
2007-09-30 $0.24B $15.52B 1.54%
2007-06-30 $0.59B $15.80B 3.81%
2007-03-31 $-3.79B $15.55B -24.95%
2006-12-31 $-3.58B $15.30B -28.69%
2006-09-30 $-3.52B $15.02B -36.24%
2006-06-30 $-3.87B $14.89B -55.73%
2006-03-31 $0.60B $4.67B 14.11%
2005-12-31 $0.63B $4.28B 14.96%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $59.335B $9.823B
Boston Scientific Corporation transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader they advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $157.266B 21.73
Abbott Laboratories (ABT) United States $154.528B 28.19
Stryker (SYK) United States $77.346B 26.01
Baxter (BAX) United States $45.725B 27.73
Essilor Luxottica (ESLOY) France $34.634B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.472B 19.12
Lonza Group Ag (LZAGY) Switzerland $27.553B 0.00
Coloplast (CLPBY) Denmark $27.281B 42.10
Terumo (TRUMY) Japan $26.781B 33.42
ResMed (RMD) United States $22.822B 42.10
Smith & Nephew SNATS (SNN) United Kingdom $21.474B 0.00
Sunny Optical Technology (SNPTF) China $20.160B 0.00
Insulet (PODD) United States $11.564B 550.18
Bio-Rad Laboratories (BIO) United States $11.268B 54.08
Canopy Growth (CGC) Canada $8.679B 0.00
Perrigo (PRGO) Ireland $7.965B 14.85
William Demant Holdings (WILYY) Denmark $7.896B 0.00
Hill-Rom Holdings (HRC) United States $7.723B 22.77
DiaSorin S.p.A (DSRLF) Italy $7.357B 0.00
GN STORE NORD (GNNDY) Denmark $6.158B 31.81
Haemonetics (HAE) United States $5.862B 39.61
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
NuVasive (NUVA) United States $4.143B 32.63
ICU Medical (ICUI) United States $4.018B 26.19
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.773B 0.00
Neogen (NEOG) United States $3.666B 61.00
GW Pharmaceuticals (GWPH) United Kingdom $3.614B 0.00
Quidel (QDEL) United States $3.223B 30.58
Agios Pharmaceuticals (AGIO) United States $2.957B 0.00
National Vision Holdings (EYE) United States $2.590B 58.46
Aurora Cannabis (ACB) Canada $2.234B 0.00
Cardiovascular Systems (CSII) United States $1.797B 0.00
TG Therapeutics (TGTX) United States $1.404B 0.00
AtriCure (ATRC) United States $1.396B 0.00
InMode (INMD) Israel $1.354B 0.00
Aphria (APHA) $1.318B 0.00
VAREX IMAGING (VREX) United States $1.203B 24.05
NanoString Technologies (NSTG) United States $1.081B 0.00
Phibro Animal Health (PAHC) United States $1.040B 19.48
PetIQ (PETQ) United States $0.862B 21.03
Eagle Pharmaceuticals (EGRX) United States $0.796B 30.50
LeMaitre Vascular (LMAT) United States $0.752B 42.25
Lantheus Holdings (LNTH) United States $0.741B 18.50
Omeros (OMER) United States $0.712B 0.00
Quanterix (QTRX) United States $0.607B 0.00
Cerus (CERS) United States $0.605B 0.00
MacroGenics (MGNX) United States $0.574B 0.00
Surmodics (SRDX) United States $0.550B 57.04
HEXO (HEXO) $0.503B 0.00
Organigram Holdings (OGI) Canada $0.490B 0.00
OraSure Technologies (OSUR) United States $0.488B 29.26
Meridian Bioscience (VIVO) United States $0.424B 14.56
Utah Medical Products (UTMD) United States $0.367B 26.55
Zynex (ZYXI) United States $0.340B 38.41
Owens & Minor (OMI) United States $0.327B 12.09
BioLife Solutions (BLFS) United States $0.325B 132.50
Bovie Medical (APYX) United States $0.280B 0.00
Female Health (VERU) United States $0.267B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.267B 0.00
Vapotherm (VAPO) United States $0.244B 0.00
United Health Products (UEEC) United States $0.224B 0.00
Repro-Med Systems (KRMD) United States $0.221B 0.00
Viemed Healthcare (VMD) United States $0.216B 22.80
Green Organic Dutchman Holdings (TGODF) Canada $0.187B 0.00
Rockwell Medical (RMTI) United States $0.178B 0.00
Liberty Health Sciences (LHSIF) Canada $0.168B 0.00
InfuSystems Holdings (INFU) United States $0.167B 840.00
Cytosorbents (CTSO) United States $0.147B 0.00
Fonar (FONR) United States $0.137B 9.67
Chimerix (CMRX) United States $0.125B 0.00
MTech Acquisition (KERN) United States $0.099B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.093B 0.00
MRI Interventions (MRIC) United States $0.092B 0.00
United-Guardian (UG) United States $0.090B 22.67
Nephros (NEPH) United States $0.078B 0.00
Chembio Diagnostics (CEMI) United States $0.073B 0.00
Surface Oncology (SURF) United States $0.068B 0.00
FSD PHARMA INC (HUGE) $0.046B 0.00
ImmuCell (ICCC) United States $0.036B 0.00
GUARDION HEALTH (GHSI) United States $0.026B 0.00
Trinity Biotech (TRIB) Ireland $0.025B 0.00
Senestech (SNES) United States $0.015B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.014B 0.00
Capricor Therapeutics (CAPR) United States $0.008B 0.00
Valeritas Holdings (VLRX) United States $0.006B 0.00
Myomo (MYO) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00